Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1983 1
1990 1
1991 1
1993 1
1994 1
1995 1
1997 2
1999 1
2000 1
2001 2
2002 3
2003 1
2005 1
2006 1
2007 2
2009 1
2011 5
2012 1
2016 1
2017 1
2018 1
2019 3
2021 1
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
How we diagnose and treat neutropenia in adults.
Palmblad J, Nilsson CC, Höglund P, Papadaki HA. Palmblad J, et al. Expert Rev Hematol. 2016 May;9(5):479-87. doi: 10.1586/17474086.2016.1142867. Epub 2016 Feb 16. Expert Rev Hematol. 2016. PMID: 26778239 Review.
Neutropenias (NPs), being acute and often transient, or chronic, range from life-threatening conditions with very low absolute neutrophil blood counts (ANC) to disorders characterized by only mild NP and of no obvious significance for health. Many are caused by gene …
Neutropenias (NPs), being acute and often transient, or chronic, range from life-threatening conditions with very low absolute …
Acalabrutinib and its use in treatment of chronic lymphocytic leukemia.
Khan Y, O'Brien S. Khan Y, et al. Future Oncol. 2019 Feb;15(6):579-589. doi: 10.2217/fon-2018-0637. Epub 2018 Nov 1. Future Oncol. 2019. PMID: 30381956 Review.
Acalabrutinib received an accelerated US FDA approval for patients with relapsed/refractory mantle cell lymphoma in 2017 and is currently being evaluated in chronic lymphocytic leukemia (CLL). To date, ibrutinib is the only Bruton tyrosine kinase (BTK) inhibitor that's …
Acalabrutinib received an accelerated US FDA approval for patients with relapsed/refractory mantle cell lymphoma in 2017 and is currently be …
[Periodic fever].
Mongil Ruiz I, Canduela Martínez V. Mongil Ruiz I, et al. An Esp Pediatr. 2002 Oct;57(4):334-44. An Esp Pediatr. 2002. PMID: 12392668 Review. Spanish.
The aim of this review is to group together these different clinical pictures, which are dispersed in the literature, to obtain an overall and detailed perspective.We classified these processes in two categories: hereditary (familial Mediterranean fever, hyper-IgD syndrome …
The aim of this review is to group together these different clinical pictures, which are dispersed in the literature, to obtain an overall a …
Neutrophil alloantigens.
Stroncek D. Stroncek D. Transfus Med Rev. 2002 Jan;16(1):67-75. doi: 10.1053/tmrv.2002.29406. Transfus Med Rev. 2002. PMID: 11788931 Review.
Antibodies to neutrophil antigens can cause neonatal alloimmune neutropenia, autoimmune neutropenia, febrile transfusion reactions, and transfusion-related acute lung injury. ...HNA-2 antigens are located on 58- to 64-Kd glycoprotein, CD177, and are encoded by a gen …
Antibodies to neutrophil antigens can cause neonatal alloimmune neutropenia, autoimmune neutropenia, febrile transfusion react …
Treatment of Lymphoid and Myeloid Malignancies by Immunomodulatory Drugs.
Fuchs O. Fuchs O. Cardiovasc Hematol Disord Drug Targets. 2019;19(1):51-78. doi: 10.2174/1871529X18666180522073855. Cardiovasc Hematol Disord Drug Targets. 2019. PMID: 29788898 Review.
Lenalidomide has also been studied in clinical trials and has shown promising activity in chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma (NHL). ...While transfusion independence (TI) after lenalidomide treatment is more than 60% in MDS patients with del(5q), o …
Lenalidomide has also been studied in clinical trials and has shown promising activity in chronic lymphocytic leukemia (CLL) and non- …
Neutropenia: causes and consequences.
Boxer L, Dale DC. Boxer L, et al. Semin Hematol. 2002 Apr;39(2):75-81. doi: 10.1053/shem.2002.31911. Semin Hematol. 2002. PMID: 11957188 Review.
Severe chronic neutropenia, lasting for more than a few weeks, can be caused by congenital marrow defects, as well as intrinsic and acquired disorders. Evaluation of patients begins with confirmation of neutropenia and examination of a blood smear. A careful …
Severe chronic neutropenia, lasting for more than a few weeks, can be caused by congenital marrow defects, as well as intrinsi …
Congenital neutropenia: diagnosis, molecular bases and patient management.
Donadieu J, Fenneteau O, Beaupain B, Mahlaoui N, Chantelot CB. Donadieu J, et al. Orphanet J Rare Dis. 2011 May 19;6:26. doi: 10.1186/1750-1172-6-26. Orphanet J Rare Dis. 2011. PMID: 21595885 Free PMC article. Review.
The term congenital neutropenia encompasses a family of neutropenic disorders, both permanent and intermittent, severe (<0.5 G/l) or mild (between 0.5-1.5 G/l), which may also affect other organ systems such as the pancreas, central nervous system, heart, muscle …
The term congenital neutropenia encompasses a family of neutropenic disorders, both permanent and intermittent, severe (<0. …
Dasatinib: an anti-tumour agent via Src inhibition.
Gnoni A, Marech I, Silvestris N, Vacca A, Lorusso V. Gnoni A, et al. Curr Drug Targets. 2011 Apr;12(4):563-78. doi: 10.2174/138945011794751591. Curr Drug Targets. 2011. PMID: 21226671 Review.
Dasatinib (BMS-354825, Sprycel) is an oral, multitargeted inhibitor of receptor tyrosine kinases (RTKs), including BCR-ABL fusion protein, stem cell factor receptor (c-KIT), platelet-derived growth factor receptor (PDGFR), and Src family kinases (SFKs). Several early- and …
Dasatinib (BMS-354825, Sprycel) is an oral, multitargeted inhibitor of receptor tyrosine kinases (RTKs), including BCR-ABL fusion protein, s …
How I treat autoimmune lymphoproliferative syndrome.
Rao VK, Oliveira JB. Rao VK, et al. Blood. 2011 Nov 24;118(22):5741-51. doi: 10.1182/blood-2011-07-325217. Epub 2011 Sep 1. Blood. 2011. PMID: 21885601 Free PMC article. Review.
Autoimmune lymphoproliferative syndrome (ALPS) represents a failure of apoptotic mechanisms to maintain lymphocyte homeostasis, permitting accumulation of lymphoid mass and persistence of autoreactive cells that often manifest in childhood with chronic nonmalignant lymphad …
Autoimmune lymphoproliferative syndrome (ALPS) represents a failure of apoptotic mechanisms to maintain lymphocyte homeostasis, permitting a …
[Periodic fever syndromes].
Huemer C, Huemer M. Huemer C, et al. Z Rheumatol. 2006 Nov;65(7):595-8, 600-3. doi: 10.1007/s00393-006-0117-5. Z Rheumatol. 2006. PMID: 17072571 Review. German.
The genetic causes of five hereditary autoinflammatory syndromes have been identified in the last few years: familial Mediterranean fever, the cryopyrinopathies [Muckle-Wells, chronic infantile neurological, cutaneous, articular syndrome (CINCA) and familial …
The genetic causes of five hereditary autoinflammatory syndromes have been identified in the last few years: familial Mediterranean f …
33 results